ImmunAbs Inc.
PrivateLast Round
Grant
Jan 31, 2024
Total Funding Raised
$34.98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ImmunAbs Inc. is a biotechnology company that develops novel antibody therapeutics for autoimmune diseases, diabetic retinopathy, and metabolic syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunAbs Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ImmunAbs Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 31, 2024 | ||||
| Series B | Nov 30, 2022 | ||||
| Grant | Nov 1, 2021 | ||||
| Series A | Sep 30, 2021 |
ImmunAbs Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| D3 Jubilee Partners | Series B |
| Seoul Investment Partners | Series B, Series A |
| CKD Venture Capital | Series B |
| Korea Drug Development Fund | Grant |
| Alpen Route | Pre Seed |
| LogInvestment | Pre Seed |
| DS Asset Management | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 482% MoM.
- Nov 30, 2022
$9.56M round with participation from CKD Venture Capital and Daekyo Investment.
ImmunAbs Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunAbs Inc.'s valuation, stock price, and market status.